X
Xenetic Biosciences D
D
XBIO
2.73000
USD
-0.50
(-15.48%)
مغلق
حجم التداول
198
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
4,210,039
الأخبار المقالات
العنوان: Xenetic Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.